Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 1/20 | 0.41 |
| ▸ | MMP2 | P08253 | 1/20 | 0.41 |
| ▸ | MMP8 | P22894 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | DPP4 | P27487 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4616011 | 1.00 | MMP1 (0.41) | MMP1MMP2MMP8L3MBTL1TDP1 | |
| SCHEMBL4560650 | 0.98 | MMP1 (0.44) | MMP1MMP2MMP8L3MBTL1TDP1 | |
| SCHEMBL8487636 | 0.83 | L3MBTL1 (0.42) | MMP1MMP2MMP8L3MBTL1TDP1 | |
| SCHEMBL5479224 | 0.81 | CYP3A4 (0.50) | L3MBTL1MEN1KMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL8483745 | 0.81 | CYP3A4 (0.50) | L3MBTL1MEN1KMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL12196226 | 0.81 | CYP3A4 (0.50) | L3MBTL1MEN1KMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL3549864 | 0.81 | CYP2C19 (0.36) | DPP7ALDH1A1EPHX2DPP4GAA | |
| SCHEMBL3544356 | 0.81 | CYP2C19 (0.36) | DPP7ALDH1A1EPHX2DPP4GAA | |
| SCHEMBL8489074 | 0.81 | L3MBTL1 (0.44) | MMP1MMP2MMP8L3MBTL1TDP1 | |
| SCHEMBL19892268 | 0.79 | ALDH1A1 (0.52) | L3MBTL1TDP1MEN1KMT2AATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080146819-A1 | Process for Preparing Levetiracetam | RUBAMIN LIMITED (IN) | 2008-06-19 | — | — | US | claimed |
| EP-1863761-A1 | PROCESS FOR PREPARING LEVETIRACETAM | Rubamin Limited (IN) | 2007-12-12 | — | — | EP | claimed |
| WO-2006095362-A1 | PROCESS FOR PREPARING LEVETIRACETAM | RUBAMIN LIMITED (IN) | 2006-09-14 | — | — | WO | claimed |
| WO-2021018012-A1 | IRAK4 KINASE INHIBITOR AND PREPARATION METHOD THEREFOR | 珠海宇繁生物科技有限责任公司 | 2021-02-04 | — | — | WO | disclosed |
| US-20080194840-A1 | Process for Preparing Levetiracetam and Racemization of (R)- and (S)-2-Amino Butynamide and the Corresponding Acid Derivatives | RUBAMIN LABORATORIES LIMITED (IN) | 2008-08-14 | — | — | US | disclosed |
| WO-2008077035-A2 | PROCESSES FOR THE PREPARATION OF LEVETIRACETAM | DR. REDDY'S LABORATORIES LTD. (IN) | 2008-06-26 | — | — | WO | disclosed |
| US-20080146819-A1 | Process for Preparing Levetiracetam | RUBAMIN LIMITED (IN) | 2008-06-19 | — | — | US | disclosed |
| US-20080146819-A1 | Process for Preparing Levetiracetam | RUBAMIN LIMITED (IN) | 2008-06-19 | — | — | US | disclosed |
| EP-1879861-A2 | PROCESS FOR PREPARING LEVETIRACETAM AND RACEMIZATION OF (R)- AND (S)-2-AMINO BUTYNAMIDE AND THE CORRESPONDING ACID DERIVATIVES | Rubamin Laboratories Limited (IN) | 2008-01-23 | — | — | EP | disclosed |
| EP-1863761-A1 | PROCESS FOR PREPARING LEVETIRACETAM | Rubamin Limited (IN) | 2007-12-12 | — | — | EP | disclosed |
| EP-1863761-A1 | PROCESS FOR PREPARING LEVETIRACETAM | Rubamin Limited (IN) | 2007-12-12 | — | — | EP | disclosed |
| WO-2006095362-A1 | PROCESS FOR PREPARING LEVETIRACETAM | RUBAMIN LIMITED (IN) | 2006-09-14 | — | — | WO | disclosed |
| WO-2006095362-A1 | PROCESS FOR PREPARING LEVETIRACETAM | RUBAMIN LIMITED (IN) | 2006-09-14 | — | — | WO | disclosed |
| EP-0828778-B1 | CLATHRATE HYDRATE INHIBITOR AND METHOD OF INHIBITING THE FORMATION OF CLATHRATE HYDRATES USING IT | NIPPON CATALYTIC CHEM IND (JP) | 2004-05-12 | — | — | EP | disclosed |
| US-6232273-B1 | MACROMOLECULAR COMPOUND WITH NITROGEN-CONTAINING RING PENDANT TO THE POLYMER CHAIN, SUCH AS POLYMER OF (METH)ACRYLOYL PYRROLIDINE, PYRROLIDINOCARBONYLETHYL (METH)ACRYLATE, 2-OXO-PYRROLIDINO-ETHYL (METH)ACRYLATE, ETC. | NIPPON SHOKUBAI CO., LTD. (JP) | 2001-05-15 | — | — | US | disclosed |
| US-5958837-A | 2-(PHENYLMETHOXY OR CARBONYLOXY-(1,4-PHENYLENE)-),3-HALO,5-HALOALKYLPYRIDINES; HERBICIDES EFFECTING DESICCATION AND DEFOLIATION OF PLANTS; GOOD ACTIVITY AND BETTER TAILORED CONTROL OF WEEDS | BASF AKTIENGESELLSCHAFT (DE) | 1999-09-28 | — | — | US | disclosed |
| EP-0802904-B1 | SUBSTITUTED 2-PHENYLPYRIDINES AS HERBICIDES | BASF AG (DE) | 1998-09-09 | — | — | EP | disclosed |
| EP-0828778-A1 | CLATHRATE HYDRATE INHIBITOR AND METHOD OF INHIBITING THE FORMATION OF CLATHRATE HYDRATES USING IT | NIPPON SHOKUBAI CO., LTD. (JP) | 1998-03-18 | — | — | EP | disclosed |
| WO-1996038492-A1 | CLATHRATE HYDRATE INHIBITOR AND METHOD OF INHIBITING THE FORMATION OF CLATHRATE HYDRATES USING IT | NIPPON SHOKUBAI CO., LTD. (JP) | 1996-12-05 | — | — | WO | disclosed |
| WO-1996021647-A1 | SUBSTITUTED 2-PHENYLPYRIDINES AS HERBICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1996-07-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080194840-A1 | Process for Preparing Levetiracetam and Racemization of (R)- and (S)-2-Amino Butynamide and the Corresponding Acid Derivatives | BCAT2, ADH1C, ABAT | MMP1 3504/4885MMP2 2846/4885MMP8 4165/4885 |
| US-20080146819-A1 | Process for Preparing Levetiracetam | ADH1C, ADH1A, ADH5 | MMP1 865/4885MMP2 1725/4885MMP8 3095/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.